Discovery of a Novel Promoter in Pathogenic Influenza
Project Number5R21AI057941-02
Contact PI/Project LeaderWENTWORTH, DAVID E
Awardee OrganizationWADSWORTH CENTER
Description
Abstract Text
DESCRIPTION (provided by applicant): The long-term goal of this project is to understand the molecular mechanisms of pathogenesis of influenza viruses. Influenza A viruses continue to cause significant disease in humans as well as many other animal species. Influenza pandemics have occurred for centuries and another pandemic that affects 20-40 million US citizens and results in tens of thousands of deaths is very probable, if not certain. Thus, it is important that we understand the processes critical to pathogenesis in order to prepare for future pandemics. Some of the mechanisms that lead to increased pathogenesis have been elegantly demonstrated (e.g., hemagglutinin cleavage). However, many molecular mechanisms important in viral pathogenesis and interspecies transmission remain elusive. Avian H5 viruses, such as the viruses responsible for 18 zoonotic infections in the "bird flu" outbreak in Hong Kong in 1997, provide a powerful model of pathogenesis because they range from avirulent to highly virulent. Furthermore, H5 influenza viruses with zoonotic potential continue to circulate and cause disease in multiple species in North America, Europe and Asia. Preliminary studies have identified a putative internal promoter in the genome of a pathogenic strain of H5 influenza. This proposal will (1) determine if a novel transcription promoter in H5 viruses results in the production of subgenomic mRNA that yields a unique protein, (2) identify a correlation between virulence and use of the putative promoter; and (3) investigate the specific nucleic acids and proteins important in the utilization of this RNA element. Addressing these specific aims will expand our understanding of influenza promoter utilization and identify processes important in pathogenesis and the emergence of pandemic and epizootic strains of influenza virus.
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
153695478
UEI
LQK1DD1EYZK9
Project Start Date
01-January-2004
Project End Date
31-December-2007
Budget Start Date
01-January-2005
Budget End Date
31-December-2007
Project Funding Information for 2005
Total Funding
$297,205
Direct Costs
$200,000
Indirect Costs
$97,205
Year
Funding IC
FY Total Cost by IC
2005
National Institute of Allergy and Infectious Diseases
$297,205
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R21AI057941-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21AI057941-02
Patents
No Patents information available for 5R21AI057941-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21AI057941-02
Clinical Studies
No Clinical Studies information available for 5R21AI057941-02
News and More
Related News Releases
No news release information available for 5R21AI057941-02
History
No Historical information available for 5R21AI057941-02
Similar Projects
No Similar Projects information available for 5R21AI057941-02